The bacterial and viral antigen experts
The Native Antigen Company (NAC) specialises in the R&D and scale up manufacturing of highly pure viral and bacterial native antigens. NAC's antigens are used primarily by pharmaceutical companies and IVD manufacturers in vaccine research and serology where high specificity and sensitivity are vital. As well as offering antigens from its rapidly expanding portfolio, the company undertakes bespoke product development and partnering.
Latest Product News
For the first time, all 4 DENV NS1 serotypes have been manufactured in human cells in response to the unmet need for highly purified, concentrated proteins for use in vaccine development and serological based diagnostic assays. Each is offered in its native folded state and possess all post-translational modifications. This advanced approach offers a product which delivers optimal antigenicity.
Highly purified toxins & toxoids of C. difficile ribotypes 027 and 078 are now available to support the increasing healthcare focus on combating these hypervirulent strains through research, vaccine development & IVD manufacturing. Offered as lyophilised preparations to confer safe transportation & long term storage.
Highly purified CMV native antigen satisfies an unmet need for high affinity towards IgG and more importantly, IgM. This new antigen also minimizes cross-reactivity and lot to lot variation making it particularly suitable for use in serology based kit manufacture.